Answer
Yes. The product information advises limiting sun exposure, wearing protective clothing and using broad-spectrum sunscreen during treatment and for two months afterwards.
Sources for this answer
- Rybrevant (amivantamab) 1600mg solution for injection — Current selected SmPCemc · Summary of Product Characteristics
- Rybrevant (amivantamab) 350mg concentrate for solution for infusion — Current selected SmPCemc · Summary of Product Characteristics